The WHO has held a closed expert meeting to identify potential vaccines for the Bundibugyo species of Ebola that is causing ...
UK-based GHO and CBC Group of Singapore – have announced a merger to create a massive player in the category with $21 billion ...
Fresh from agreeing a wide-ranging alliance with Regeneron worth up to $2.3 billion, Parabilis Medicines has decided to ...
Neuroscience isn't currently one of the top strategic R&D priorities at GSK, but a new alliance with ABL Bio adds to the sense that its focus may be shifting. The UK-headquartered pharma group is ...
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Ramy Younes, corporate vice president, global head of ...
A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major ...
A phase 2 trial of Sanofi's experimental therapy for alpha-1 antitrypsin deficiency (AATD) has raised the hope of an ...
The US Supreme Court has rejected lawsuits from pharma groups challenging Medicare's drug pricing negotiation powers, saying ...
An analysis by pharma trade body EFPIA has found "widening equality" in the access to new medicines across 36 European countries that could be compounded by the introduction of the Most Favoured ...
Novartis has reported new data to support its drive to expand the label of its radioligand therapy Pluvicto to include ...
The FDA has approved AstraZeneca's aldosterone synthase inhibitor (ASI) – baxdrostat – for hard-to-treat hypertension, making ...
As deaths from an Ebola virus outbreak in the Democratic Republic of Congo and Uganda have risen above 80, the World Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results